Waters Corporation
$332.95
▼
-0.68%
2026-04-22 10:12:13
www.waters.com
NYQ: WAT
Explore Waters Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$32.76 B
Current Price
$332.95
52W High / Low
$414.15 / $275.05
Stock P/E
30.93
Book Value
$43.01
Dividend Yield
—
ROCE
20.92%
ROE
29.28%
Face Value
—
EPS
$10.76
Exp Qtr EPS
—
Sector
Healthcare
Industry
Diagnostics & Research
Employees
7,900
Beta
1.2
Debt / Equity
60.28
Current Ratio
1.73
Quick Ratio
1.27
Forward P/E
19.56
Price / Sales
9.92
Enterprise Value
$32.35 B
EV / EBITDA
29.57
EV / Revenue
10.22
Rating
Buy
Target Price
$389.05
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Labcorp Holdings Inc. | $271.17 | 25.93 | $22.36 B | 1.07% | 9.74% | 10.51% | $293.72 / $209.38 | $104.86 |
| 2. | Myriad Genetics, Inc. | $5.14 | — | $484.84 M | — | -11.84% | -23.51% | $8.59 / $3.76 | $3.94 |
| 3. | Quest Diagnostics Incorporated | $200.41 | 22.15 | $22.16 B | 1.76% | 11.16% | 14.75% | $213.5 / $160.02 | $65.18 |
| 4. | XWELL, Inc. | $1.2 | — | $9.7 M | — | -75.03% | -275.96% | $2.2 / $0.26 | $-1.1 |
| 5. | bioAffinity Technologies, Inc. | $2.69 | — | $12.87 M | — | -131.93% | -3.02% | $17.44 / $0.69 | $1.62 |
| 6. | Qiagen N.V. | NOT FOUND | — | — | 0.64% | 9.02% | 11.57% | $57.81 / $38.8 | $18.33 |
| 7. | Fulgent Genetics, Inc. | $16.18 | — | $481.31 M | — | -8.07% | -5.51% | $31.04 / $13.46 | $35.78 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 932.36 M | 799.89 M | 771.33 M | 661.71 M | 872.71 M | — |
| Operating Profit | 270.52 M | 192.11 M | 188.21 M | 151.75 M | 292.26 M | — |
| Net Profit | 225.21 M | 148.92 M | 147.11 M | 121.38 M | 231.4 M | — |
| EPS in Rs | 2.29 | 1.52 | 1.5 | 1.24 | 2.36 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 3.17 B | 2.96 B | 2.96 B | 2.97 B |
| Operating Profit | 802.59 M | 837.92 M | 817.68 M | 883.19 M |
| Net Profit | 642.63 M | 637.83 M | 642.23 M | 707.75 M |
| EPS in Rs | 6.55 | 6.5 | 6.54 | 7.21 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 5.08 B | 4.55 B | 4.63 B | 3.28 B |
| Total Liabilities | 2.52 B | 2.73 B | 3.48 B | 2.78 B |
| Equity | 2.56 B | 1.83 B | 1.15 B | 504.49 M |
| Current Assets | 2.15 B | 1.67 B | 1.75 B | 1.76 B |
| Current Liabilities | 1.24 B | 789.76 M | 789.58 M | 785.74 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 652.55 M | 762.12 M | 602.81 M | 611.66 M |
| Investing CF | -152.25 M | -143.09 M | -1.44 B | -107.97 M |
| Financing CF | -237.21 M | -696.67 M | 754.95 M | -509.63 M |
| Free CF | 539.81 M | 619.64 M | 442.18 M | 428.2 M |
| Capex | -112.75 M | -142.48 M | -160.63 M | -183.46 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 0.07% | -0.52% | — | — |
| Earnings Growth % | -0.69% | -9.26% | — | — |
| Profit Margin % | 21.56% | 21.72% | 23.81% | — |
| Operating Margin % | 28.32% | 27.66% | 29.72% | — |
| Gross Margin % | 59.43% | 59.57% | 58% | — |
| EBITDA Margin % | 35.03% | 33.86% | 34.22% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.